Covered recipient · General Payments record
MARY B LEE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$456.62
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.64 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.69 | 2 |
| Exact Sciences Corporation | $40.60 | 2 |
| GlaxoSmithKline, LLC. | $38.72 | 2 |
| Amgen Inc. | $32.36 | 2 |
| Lilly USA, LLC | $31.73 | 2 |
| Mylan Specialty L.P. | $26.47 | 1 |
| ABBVIE INC. | $18.68 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.70 | 1 |
| Currax Pharmaceuticals LLC | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.68 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107523078 | CMS |
| Amgen Inc. | $15.38 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307580 | CMS |
| Amgen Inc. | $16.98 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307578 | CMS |
| Boston Scientific Corporation | $14.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092682031 | CMS |
| Currax Pharmaceuticals LLC | $13.69 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089523819 | CMS |
| Exact Sciences Corporation | $23.55 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114428308 | CMS |
| Exact Sciences Corporation | $17.05 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114428312 | CMS |
| GlaxoSmithKline, LLC. | $21.37 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116278830 | CMS |
| GlaxoSmithKline, LLC. | $17.35 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580609 | CMS |
| Lilly USA, LLC | $18.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135743948 | CMS |
| Lilly USA, LLC | $13.57 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135778902 | CMS |
| Mylan Specialty L.P. | $26.47 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147298958 | CMS |
| Novo Nordisk Inc | $17.56 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100565920 | CMS |
| Novo Nordisk Inc | $27.13 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100519679 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.